Dr. Rayhill Interviewed on Clinical Trials for Cluster Headache

Melissa Rayhill, MD, Assistant Professor of Neurology at the Univ. at Buffalo Jacobs School of Medicine and Biomedical Sciences and director of the headache program, was recently interviewed by MedPage Today.  In a recent study that Dr. Rayhill and colleagues presented at the American Neurological Association meeting held in October 2016, surveys of patients with cluster headache indicated that 86% were accepting of placebo control arms in preventive drug trials.  Patients were less accepting of placebo controls in surgical device or abortive drug trials, however.  Dr. Rayhill noted that patients’ lack of success with preventive measures likely influenced the higher acceptance rate of placebo in those types of studies.  She also emphasized the importance of understanding cluster headache patient preferences to properly design clinical trials for the condition since “cluster headache is one of the most painful conditions known to man.”   For further details, please see http://www.medpagetoday.com/clinical-context/migraines/60864

Melissa Rayhill, MD

Melissa Rayhill, MD


UB Neurology/Neurosurgery Recognized by US News & World Report

The neurology and neurosurgery services at Buffalo General Medical Center were recently recognized as high performing in the annual US News & World Report ranking. In addition, the hospital was ranked #15 overall of more than 200 hospitals in the state. Only two Western New York hospitals received a higher ranking — Univ. of Rochester Medicine Strong Memorial and Rochester General hospitals.

Wolfe co-chairs international panel to develop treatment recommendations for myasthenia gravis

Gil I. Wolfe, MD, Irvin and Rosemary Smith Professor and Chair of the UB Department of Neurology, along with his colleague from Duke University Medical Center, Donald Sanders, MD, has co-chaired the first-ever international panel of myasthenia gravis (MG) experts that developed consensus-based treatment recommendations for the disease.  A variety of topics were covered including symptomatic and immunosuppressive therapy, plasma exchange and intravenous immunoglobulin, MG crisis, thymectomy, juvenile MG, and MG in pregnancy.  The consensus statement was published in July 2016 in the journal Neurology (see Intl MG Rx statement 7.16).   The panel’s work was supported by a grant from the MG Foundation of America.

Gil I. Wolfe, MD, FAAN

Gil I. Wolfe, MD, FAAN


UB Dept. of Neurology Celebrates Annual Research Day and Graduation

The UB Dept. of Neurology held its annual Michael E. Cohen, MD, Residents Research Day and Graduation Banquet on June 10, 2016.  All graduating residents presented their research findings, while the PGY-3 level residents presented research plans.  The Research Day was coordinated by Dr. Robert Zivadinov and his Buffalo Neuroimaging Analysis Center staff.  Winners of the Outstanding Resident Presentation Awards for Research Day were Haris Kamal and Aurangzeb Memon, both PGY4s and outgoing co-chief residents, and Svetlana Eckert, PGY3 and incoming co-chief resident.  The Research Day program is available here: Research Day 2016 Program.

At the Graduation Dinner banquet, Ashish Arora, PGY3 and incoming co-chief resident, and Lindsay Dudeck received the teaching award from the medical students.  Resident collegiality awards were given to Adnan Khan, PGY4, Brian Trummer, PGY3, and Khaleeq Ahmed, PGY2.  Graduating residents were Drs. Farid Din, Lindsay Dudeck, Haris Kamal, Adnan Khan, Emily Langan and Aurangzeb Memon.  Graduating neurophysiology fellows were Drs. Mei Jiang and Pooja Sofat.  Drs. Sarah Finnegan, Norah Lincoff, and Ashkan Mowla each received Faculty Teaching Awards.  Eva Tamoga and Thomas Ballanca, administrative support staff for the training programs, played key roles in organizing the banquet.


Dr. Norah Lincoff with Chief Residents Haris Kamal (l) and Aurangzeb Memon (r)

Tom and Emily Langan receive grant, award

Tom Langan, MD, Associate Professor of Neurology, received notification last month that his R21 grant application has been funded by NIH/Eunice Kennedy Shriver National Institute of Child Health and Human Development.  Dr. Langan is a co-PI along with Randolph Carter, PhD.  The grant will provide funding for the enhancement of newborn screening in Krabbe disease, with the hope of improving the outcomes from cord blood transplants for this form of childhood leukodystrophy.  Dr. Langan directs the clinical program for the Hunter James Kelly Research Institute.

Meanwhile, Emily Langan, MD, his daughter, has been selected to receive the 2016 Resident Award for Excellence for Promoting Inclusion and Cultural Diversity.  Emily Langan is a senior child neurology resident in the department.  The award is sponsored by the Office of Inclusion and Cultural Enhancement at the Univ. at Buffalo Jacobs School of Medicine and Biomedical Sciences.  An example of the apple not falling far from the tree.  Congrats to both of our Dr. Langans!!

Thomas Langan, MD

Thomas Langan, MD

Langan Emily

Emily Langan, MD

Dr. Ashkan Mowla Recognized with Siegel Award for Teaching Excellence

Ashkan Mowla, MD, Assistant Professor of Neurology and a member of the stroke division, received Honorable Mention recognition at the annual presentation of the Louis A. and Ruth Siegel Awards for Excellence in Teaching.  The ceremony was held on April 13, 2016.  This is the second time that Dr. Mowla has received teaching recognition from medical students at the Univ. at Buffalo Jacobs School of Medicine and Biomedical Sciences.   Comments from medical students praised Dr. Mowla for his warmth and respectful approach to patients, his ability to tailor his teaching to different audiences, and his encouragement of critical thinking.  The Siegel Awards are the only ones given by the medical school to recognize faculty for teaching excellence.  Nominees are chosen by a committee of medical students followed by voting in several categories that include both clinical and pre-clinical teaching.

Ashkan Mowla, MD

Ashkan Mowla, MD

National Association of Epilepsy Centers Again Recognizes Epilepsy Division

The National Association of Epilepsy Centers (NAEC) has again recognized the Epilepsy Division of the Univ. at Buffalo Department of Neurology with a Level 4 designation.   Level 4 is the highest designation offered by the NAEC and recognizes professional expertise and facilities that enable “the highest level of medical and surgical evaluation and treatment for patients with complex epilepsy.”  The long-term monitoring unit for epilepsy evaluation is housed in Kaleida Health’s Women and Children’s Hospital in Buffalo and is expanding to 12 beds in the new John R. Oishei Children’s Hospital being built on the downtown Buffalo Niagara Medical Campus.  Dr. Arie Weinstock, Professor of Neurology and Chief of Child Neurology, directs the epilepsy program at UB.

(Standing l to r): Drs. Novreen Shahdad, Alyssa Fidder, Salomi Salins, Ping Li, Kevin Potts REEGT, Osman Farooq, Susan Kerr, Robert Miletich, Arie Weinstock. (Seated l to r): Drs. Veetai Li, Renee Reynolds, Joy Parrish.  Not present was Dr. Sarah Finnegan.

(Standing l to r): Drs. Novreen Shahdad, Alyssa Fidder, Salomi Salins, Ping Li, Kevin Potts REEGT, Osman Farooq, Susan Kerr, Robert Miletich, Arie Weinstock. (Seated l to r): Drs. Veetai Li, Renee Reynolds, Joy Parrish. Not present was Dr. Sarah Finnegan.